Approves Acadia Pharmaceuticals Announces Health Canada Approval of DAYBUE (trofinetide) for the Treatment of Rett Syndrome. DAYBUE is the first and only therapy approved in Canada for the treatment of Rett syndrome, a rare neurodevelopmental disorder. We recognize the… Read More
Light Canada Purple Submissions
Leave a Comment
Last Updated: 10/25/2024 by Steve
We would love to see your photos of iconic locations or local supporters that were lit purple for Rett Syndrome.
Light Canada Purple
Leave a Comment
Last Updated: 10/26/2024 by Steve
Our National LightCanadaPurple Campaign For More On Our Ontario Locations See More
DAYBUE – Breaking News
Leave a Comment
Last Updated: 10/17/2024 by Steve
Approves Acadia Pharmaceuticals Announces Health Canada Approval of DAYBUE (trofinetide) for the Treatment of Rett Syndrome. DAYBUE is the first and only therapy approved in Canada for the treatment of Rett syndrome, a rare neurodevelopmental disorder. We recognize the… Read More